Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Ignyta, Inc.
Scientific Title
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements